Biocomposites’ STIMULAN® and genex® products have been added to the NHS Supply Chain’s Total Orthopaedic Solutions 2 (TOS2) framework agreement. NHS Supply Chain manages the sourcing, delivery and supply of healthcare products and services for NHS trusts and healthcare organizations across England and Wales, and TOS2 provides a single source for NHS Trusts to purchase orthopedic products.
STIMULAN recently gained a new CE Mark approval for mixing with the antibiotics vancomycin, gentamicin and tobramycin, for use in infected bone and soft tissue. STIMULAN is the only product of its type available through the TOS2 agreement.
Biocomposites CEO Michael Harris said, “STIMULAN is already used in over 50,000 cases every year in thousands of hospitals around the world. As the only calcium sulfate antibiotic carrier approved for use in bone and soft tissue, our addition to TOS2 makes it even easier for hospitals and surgeons to access this breakthrough solution as part of their infection management strategy.”
Biocomposites' STIMULAN® and genex® products have been added to the NHS Supply Chain's Total Orthopaedic Solutions 2 (TOS2) framework agreement. NHS Supply Chain manages the sourcing, delivery and supply of healthcare products and services for NHS trusts and healthcare organizations across England and Wales, and TOS2 provides a single source for...
Biocomposites’ STIMULAN® and genex® products have been added to the NHS Supply Chain’s Total Orthopaedic Solutions 2 (TOS2) framework agreement. NHS Supply Chain manages the sourcing, delivery and supply of healthcare products and services for NHS trusts and healthcare organizations across England and Wales, and TOS2 provides a single source for NHS Trusts to purchase orthopedic products.
STIMULAN recently gained a new CE Mark approval for mixing with the antibiotics vancomycin, gentamicin and tobramycin, for use in infected bone and soft tissue. STIMULAN is the only product of its type available through the TOS2 agreement.
Biocomposites CEO Michael Harris said, “STIMULAN is already used in over 50,000 cases every year in thousands of hospitals around the world. As the only calcium sulfate antibiotic carrier approved for use in bone and soft tissue, our addition to TOS2 makes it even easier for hospitals and surgeons to access this breakthrough solution as part of their infection management strategy.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
